Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,135.00
-23.00 (-1.99%)
Sep 19, 2025, 2:35 PM KST

Enzychem Lifesciences Revenue

Enzychem Lifesciences had revenue of 16.40B KRW in the quarter ending June 30, 2025, a decrease of -16.34%. This brings the company's revenue in the last twelve months to 72.71B, down -14.28% year-over-year. In the year 2024, Enzychem Lifesciences had annual revenue of 77.38B with 1.76% growth.

Revenue (ttm)
72.71B
Revenue Growth
-14.28%
P/S Ratio
1.24
Revenue / Employee
559.33M
Employees
130
Market Cap
89.90B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202477.38B1.34B1.76%
Dec 31, 202376.04B49.40B185.46%
Dec 31, 202226.64B3.66B15.94%
Dec 31, 202122.98B-2.84B-11.01%
Dec 31, 202025.82B-5.65B-17.96%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics5,031.69B
Celltrion3,748.95B
ALTEOGEN158.06B
Yuhan2,165.44B
SK Biopharmaceuticals620.28B
Peptron5.18B
PharmaResearch449.81B
LigaChem Biosciences148.28B
Revenue Rankings